Endo-histologic outcomes in patients with ulcerative colitis responding to tofacitinib

被引：0
|
作者：
Singh, D. M. A. [1 ]
Bhardwaj, A. [1 ]
Jain, D. [1 ]
Sharma, R. [1 ]
Singh, D. [1 ]
Mahajan, R. [1 ]
Kaur, K. [2 ]
Singh, A. [3 ]
Narang, V [3 ]
Kaur, H. [3 ]
Singh, M. [4 ]
Gupta, P. [4 ]
Sehgal, T. [4 ]
Midha, V [4 ]
Sood, A. [1 ]
机构：
[1] Dayanand Med Coll & Hosp, Gastroenterol, Ludhiana, India
[2] Dayanand Med Coll & Hosp, Pharmacol, Ludhiana, India
[3] Dayanand Med Coll & Hosp, Pathol, Ludhiana, India
[4] Dayanand Med Coll & Hosp, Med, Ludhiana, India
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.1278
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1104
引用
收藏
页码：i2033 / i2034
页数：2
相关论文
共 50 条
  • [31] Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis
    Colombel, Jean-Frederic
    Osterman, Mark T.
    Thorpe, Andrew J.
    Salese, Leonardo
    Nduaka, Chudy I.
    Zhang, Haiying
    Lawendy, Nervin
    Friedman, Gary S.
    Quirk, Daniel
    Su, Chinyu
    Reinisch, Walter
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (01) : 116 - +
  • [32] Tofacitinib for the treatment of ulcerative colitis
    Fernandez-Clotet, Agnes
    Castro-Poceiro, Jesus
    Panes, Julian
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (11) : 881 - 892
  • [33] Acute histologic inflammatory activity and postoperative outcomes in pediatric patients with ulcerative colitis
    Onwuka, Ekene
    Huntington, Justin
    Onwuka, Amanda
    Prasad, Vinay
    Nwomeh, Benedict
    AMERICAN JOURNAL OF SURGERY, 2020, 219 (04): : 592 - 597
  • [34] THE EFFECT OF TOFACITINIB ON SERUM LIPIDS AND CARDIOVASCULAR SAFETY IN PATIENTS WITH ULCERATIVE COLITIS - RESULTS FROM THE TOFACITINIB ULCERATIVE COLITIS CLINICAL PROGRAM
    Sands, Bruce E.
    Taub, Pam R.
    Feagan, Brian G.
    Armuzzi, Alessandro
    Friedman, Gary S.
    Moscariello, Michele
    Lawendy, Nervin
    Pedersen, Ronald D.
    Chan, Gary
    Nduaka, Chudy I.
    Quirk, Daniel
    Salese, Leonardo
    Su, Chinyu
    GASTROENTEROLOGY, 2018, 154 (06) : S380 - S380
  • [35] The effect of tofacitinib on serum lipids and cardiovascular safety in patients with ulcerative colitis: results from the tofacitinib ulcerative colitis clinical programme
    Sands, B. E.
    Taub, P. R.
    Feagan, B. G.
    Armuzzi, A.
    Friedman, G. S.
    Moscariello, M.
    Lawendy, N.
    Pedersen, R. D.
    Chan, G.
    Nduaka, C. I.
    Quirk, D.
    Salese, L.
    Su, C.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S23 - S23
  • [36] Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates in the Tofacitinib Ulcerative Colitis Clinical Program
    Winthrop, Kevin L.
    Loftus, Edward V., Jr.
    Baumgart, Daniel C.
    Salese, Leonardo
    Thorpe, Andrew J.
    Lawendy, Nervin
    Chan, Gary
    Pedersen, Ronald D.
    Reinisch, Walter
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S427 - S429
  • [37] PREVALENCE AND PREDICTORS OF PERSISTENT GASTROINTESTINAL SYMPTOMS IN PATIENTS WITH CROHN'S DISEASE IN ENDO-HISTOLOGIC REMISSION
    Tse, Chung Sang
    Singh, Siddharth
    Neill, Jennifer
    Le, Helen
    Boland, Brigid S.
    GASTROENTEROLOGY, 2022, 162 (07) : S620 - S620
  • [38] Editorial: impact of body mass index on clinical outcomes in patients with ulcerative colitis treated with tofacitinib
    Tassone, Daniel
    Singh, Siddharth
    Sheng Ding, Nik
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (02) : 206 - 207
  • [39] The effect of tofacitinib on serum lipids and cardiovascular safety in patients with ulcerative colitis: updated results from the tofacitinib ulcerative colitis clinical programme
    Sands, B. E.
    Taub, P. R.
    Feagan, B. G.
    Armuzzi, A.
    Damiao, A. O.
    Lawendy, N.
    Solano, G.
    Kwok, K.
    Woolcott, J.
    Salese, L.
    Su, C.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S557 - S558
  • [40] SAFETY OF TOFACITINIB ON POSTOPERATIVE OUTCOMES AFTER SUBTOTAL COLECTOMY IN ULCERATIVE COLITIS
    Kani, Haluk T.
    Esen, Eren
    Chang, Shannon
    Hudesman, David
    Remzi, Feza H.
    Axelrad, Jordan E.
    GASTROENTEROLOGY, 2020, 158 (06) : S677 - S677
12345